Showing results (2601-2610 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 27, 2013
Vesicular nucleotide transport: a brief history and the vesicular nucleotide transporter as a target for drug developmentMiki Hiasa, Natsuko Togawa, Yoshinori MoriyamaCurrent Pharmaceutical Design|July 30, 2013
The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological featuresShaohua Xu, Peizhen Xu, Wei Wu, et al.Current Pharmaceutical Design|July 30, 2013
Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21Honglei Tu, Haibing Sun, Yan Lin, et al.Current Pharmaceutical Design|July 30, 2013
Folate deficiency and aberrant expression of DNA methyltransferase 1 were associated with cervical cancerizationJin-tao Wang, Ling Ding, Shi-Wen Jiang, et al.Current Pharmaceutical Design|July 30, 2013
HDAC inhibitor sodium butyrate augments the MEF2C enhancement of Nampt expression under hypoxiaShao-Fei Yan, Hong-Jie You, Tian-Yu Xing, et al.Current Pharmaceutical Design|July 30, 2013
Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitorYunlong Zhao, Xiuli Fang, Ye Wang, et al.Current Pharmaceutical Design|July 30, 2013
Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cellsShaohua Xu, Juan Ren, Hai Bin Chen, et al.Current Pharmaceutical Design|July 30, 2013
Driven hematopoietic differentiation of embryonic stem cells: epigenetic perspectivesLenka Tesarova, Stanislav Stejskal, Irena KoutnaCurrent Pharmaceutical Design|July 30, 2013
Sirtuins: nodes connecting aging, metabolism and tumorigenesisYisha Yao, Yang Yang, Wei-Guo ZhuCurrent Pharmaceutical Design|July 30, 2013
Epigenetic regulation of EMT: the Snail storyYiwei Lin, Chenfang Dong, Binhua P ZhouPageof 1,008